top of page
DNA Helix Structure

Industry Practicum Projects

From Barnyard to Breakthrough: A look at the Swine Respiratory Drug Market
Fall 2024 CMI-BAM Project

This mini-project at the beginning of the semester explored the swine respiratory drug market and potential methods of funding for Dr. Elisa Crisci of NCSU. Her lab is working to develop a novel therapeutic called BIO-PLY, a PRP lysate to treat Porcine Reproductive and Respiratory Virus (PRRSV), a viral disease that infects domestic swine, potentially leading to respiratory failure and pneumonia. Click the image below to review our final presentation. 

Mentor Copy of Presentation CMI_Team 2.jpg

Kitari Bio: AI For Pesticide Protein Discovery 
Spring 2025 Industry Practicum Project

This semester-long project partnered with Kitari Bio, an AI startup company, to gather information on the pesticide market and potential partners for this company. We completed market analysis and interviews with potential customers and key opinion leaders in pesticide discovery to understand industry perspectives and how AI is being used in this space currently. Our mid-project update presentation is available for review by clicking the image below. 

Kitari Mid-Project Update.jpg

Microbes to the Rescue: Probiotics Giving Animal Agriculture a Boost
Fall 2024 Industry Practicum Project

This semester-long project partnered with Novonesis to gather information on probiotics and enzyme use in the animal agriculture market. We completed market analysis and surveys of key opinion leaders in this market to understand industry perspectives on the use of these products. Click the image below to review our final presentation. 

Novonesis Final Presentation.jpg

Ad Astra Diagnostics:  
Fall 2025 Industry Practicum Project

This semester-long project allowed for partnership with Ad Adstra Diagnostics, a human diagnostic company. Our goal was to evaluate market potential, determine ATE values, and prepare FDA documentation and justification for their novel point-of-care CBC test. Our team conducted significant research to determine and find justification for Allowable Total Error values, as well as performing case studies, outreach, and surveys to evaluate the value of this product for clinicians and patients.  Our mid-project update presentation is available for review by clicking the image below. *Final presentation available soon.*

Screenshot 2025-11-19 215924.png
bottom of page